atovaquone
Generic: atovaquone
Labeler: pai holdings, llc dba pai pharmaDrug Facts
Product Profile
Brand Name
atovaquone
Generic Name
atovaquone
Labeler
pai holdings, llc dba pai pharma
Dosage Form
SUSPENSION
Routes
Active Ingredients
atovaquone 750 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
0121-0956
Product ID
0121-0956_3dd9fcd8-8f05-43cb-a095-756f191f703d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214272
Listing Expiration
2026-12-31
Marketing Start
2025-04-04
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01210956
Hyphenated Format
0121-0956
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
atovaquone (source: ndc)
Generic Name
atovaquone (source: ndc)
Application Number
ANDA214272 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/5mL
Packaging
- 1 BOTTLE in 1 CARTON (0121-0956-08) / 210 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3dd9fcd8-8f05-43cb-a095-756f191f703d", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["df6086d3-6100-422a-bf23-e9610027749b"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0121-0956-08) / 210 mL in 1 BOTTLE", "package_ndc": "0121-0956-08", "marketing_start_date": "20250404"}], "brand_name": "Atovaquone", "product_id": "0121-0956_3dd9fcd8-8f05-43cb-a095-756f191f703d", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "0121-0956", "generic_name": "Atovaquone", "labeler_name": "PAI Holdings, LLC dba PAI Pharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA214272", "marketing_category": "ANDA", "marketing_start_date": "20250404", "listing_expiration_date": "20261231"}